'Antiflammins': Two Nonapeptide Fragments of Uteroglobin and Lipocortin I Have No Phospholipase A2-inhibitory and Anti-inflammatory Activity
Overview
Authors
Affiliations
The 'antiflammin' nonapeptides P1 and P2 [(1988) Nature 335, 726-730] were synthesized and tested for inhibition of phospholipase A2 and release of prostaglandin E2 and leukotriene C4 in stimulated cells in vitro, and in vivo for anti-inflammatory activity in rats with carrageenan-induced paw oedema. Porcine pancreatic phospholipase A2 was not inhibited at concentrations of 0.5-50 microM. Prostaglandin E2 and leukotriene C4 release by mouse macrophages stimulated with zymosan or ATP was not affected up to a concentration of 10 microM, nor was prostaglandin release by interleukin 1 beta-stimulated mesangial cells and angiotensin II-stimulated smooth muscle cells. Both peptides exhibited no anti-inflammatory activity in carrageenan-induced rat paw oedema after topical (250 micrograms/paw) or systemic administration (1 or 4 mg/kg s.c.). These results do not support the claim of potent phospholipase A2-inhibitory and anti-inflammatory activity of the 'antiflammins' P1 and P2.
Uteroglobin, a possible ligand of the lipoxin receptor inhibits serum amyloid A-driven inflammation.
Antico G, Aloman M, Lakota K, Miele L, Fiore S, Sodin-Semrl S Mediators Inflamm. 2014; 2014:876395.
PMID: 24782597 PMC: 3981015. DOI: 10.1155/2014/876395.
Sautebin L, Cirino G, Rosa M Mediators Inflamm. 1992; 1(4):251-4.
PMID: 18475469 PMC: 2365348. DOI: 10.1155/S0962935192000383.
Antiflammin-2 activates the human formyl-peptide receptor like 1.
Kamal A, Hayhoe R, Paramasivam A, Cooper D, Flower R, Solito E ScientificWorldJournal. 2006; 6:1375-84.
PMID: 17072491 PMC: 1868079. DOI: 10.1100/tsw.2006.247.
Oxidative degradation of antiflammin 2.
Ye J, Wolfe J Pharm Res. 1996; 13(2):250-5.
PMID: 8932445 DOI: 10.1023/a:1016095131836.
Uptake and accumulation of tritiated uteroglobin by day-6 rabbit blastocysts.
Dannhorn D, Kirchner C Cell Tissue Res. 1990; 262(3):569-77.
PMID: 2078860 DOI: 10.1007/BF00305254.